ArticlePharmacoepidemiology and drug safety2023

Maternal cyclobenzaprine exposure and risk of birth defects in the National Birth Defects Prevention Study (1997-2011) and Birth Defects Study to Evaluate Pregnancy exposureS (2014-2018).

Sarah C Fisher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.